EDGAR Filing Documents for 0001193125-22-216382

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001193125-22-216382

Filing Date

2022-08-10

Accepted

2022-08-09 18:54:27

Documents

Period of Report

2022-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	d385474d6k.htm iXBRL	6-K	111598
2	EX-99.1	d385474dex991.htm	EX-99.1	31992
3	EX-99.2	d385474dex992.htm	EX-99.2	833880
4	EX-99.3	d385474dex993.htm iXBRL	EX-99.3	950797
5	EX-99.4	d385474dex994.htm	EX-99.4	18135
6	EX-99.5	d385474dex995.htm	EX-99.5	18804
12	GRAPHIC	g385474dsp1.jpg	GRAPHIC	4016
13	GRAPHIC	g385474img164290822_0.jpg	GRAPHIC	7871
14	GRAPHIC	g385474img165214343_0.jpg	GRAPHIC	12046
	Complete submission text file	0001193125-22-216382.txt		6260678

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	lmnl-20220630.xsd	EX-101.SCH	58544
8	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	lmnl-20220630_cal.xml	EX-101.CAL	49222
9	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	lmnl-20220630_def.xml	EX-101.DEF	187583
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	lmnl-20220630_lab.xml	EX-101.LAB	346528
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	lmnl-20220630_pre.xml	EX-101.PRE	296912
65	EXTRACTED XBRL INSTANCE DOCUMENT	d385474d6k_htm.xml	XML	986605

Mailing Address 440 ARMAND-FRAPPIER BLVD. SUITE 300 LAVAL A8 H7V 4B4

Business Address 231 DUNDAS STREET EAST BELLEVILLE A6 K8N 1E2 450-781-0115

Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)